Home/Filings/4/0001404644-25-000021
4//SEC Filing

Jordan Julie 4

Accession 0001404644-25-000021

CIK 0001404644other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 9:28 PM ET

Size

7.6 KB

Accession

0001404644-25-000021

Insider Transaction Report

Form 4
Period: 2025-03-26
Jordan Julie
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2025-03-26+8,4008,400 total
  • Award

    Employee Stock Option (Right to buy)

    2025-03-26+50,30050,300 total
    Exercise: $16.14Exp: 2035-03-26Common Stock (50,300 underlying)
Footnotes (2)
  • [F1]Consist of 8,400 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date.
  • [F2]This option represents the right to purchase 50,300 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.

Issuer

Neurogene Inc.

CIK 0001404644

Entity typeother

Related Parties

1
  • filerCIK 0001968554

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 9:28 PM ET
Size
7.6 KB